Global Optogenetics Market Size and Forecast to 2029: Revenue, Growth, and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the optogenetics market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Optogenetics Market Size Today And What Will Its Value Be At The End Of 2029?

The optogenetics market has seen substantial growth recently. Its value is expected to rise from $35.91 billion in 2024 to $40.9 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.9%. This historical expansion can be credited to factors such as a surge in neurological disorders, increased investment in life sciences, advancements in drug discovery and development, the mapping of neural circuits, the use of optogenetics in drug screening, and progress in neurophotonics.

The optogenetics market is projected for swift expansion over the coming years. This market is predicted to reach $71.21 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.9%. Key drivers for this growth during the forecast period include therapeutic applications, the progression of clinical trials and translation, its application in non-neuronal cells, the role of optogenetics in brain-machine interfaces, and the creation of innovative light-sensitive proteins. Significant trends anticipated for the forecast period encompass improvements in optogenetic tools and technologies, collaborations with pharmaceutical firms, the utilization of optogenetics in drug discovery and development, its extended use in non-neural cell types, and its combination with other imaging techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Which Key Drivers Are Powering Growth In The Optogenetics Market?

The increasing prevalence of Parkinson’s disease and epilepsy is anticipated to stimulate the expansion of the optogenetics market in the future. Parkinson’s disease (PD) is a brain’s degenerative disorder leading to motor symptoms like slow movement, tremors, rigidity, and imbalance, along with other issues such as cognitive decline, mental health problems, sleep disturbances, pain, and sensory impairments. Epilepsy is a neurological disorder characterized by seizures. Optogenetic therapy employs light-sensitive proteins to manage Parkinson’s disease. Through gene therapy, these proteins can be engineered to either activate or inactivate when exposed to particular light wavelengths, thereby restoring normal brain function in Parkinson’s disease (PD). For example, in December 2022, The Parkinson’s Foundation, a US-based organization dedicated to improving the lives of individuals affected by Parkinson’s disease, reported a significant increase in annual Parkinson’s disease diagnoses to nearly 90,000, substantially higher than the prior estimate of 60,000. Furthermore, the population suffering from PD in the U.S. is projected to grow to 1.2 million by 2030, an increase from 930,000 in 2020. Consequently, the global surge in Parkinson’s disease and epilepsy cases is propelling the optogenetics market’s advancement.

Which Segment Categories Are Driving Maximum Growth In The Optogenetics Market?

The optogeneticsmarket covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

What Key Trends Are Driving Growth In The Optogenetics Market?

A significant trend gaining popularity in the optogenetics market is the creation of innovative systems. Major companies operating within the optogenetics market are developing novel optogenetics tools and solutions using cutting-edge technologies to sustain their market position. For instance, in June 2022, Bruker Corporation, a US-based optogenetics tool manufacturer company, launched NeuraLight 3D Ultra, an improved 3D holographic stimulation for optogenetics module designed to support advanced neuroscience and optogenetics research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra offers state-of-the-art 3D holographic photostimulation specifically tailored for in-depth functional research on neural networks and brain computation.

Who Are The Leading Companies Driving The Optogenetics Market?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Which Region Holds The Largest Share In The Optogenetics Market Today?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

Browse Through More Reports Similar to the Global Optogenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795